Home
Our Team
About
Technology
Pipeline
Partnerships
Investors
News & Events
Stock Information
Corporate Governance
Financials
Investor Resources
Careers
Contact
Select Page
VANCE: First in Human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine
Jun 5, 2018
View/Download ASCO 2018 Poster
Search for:
Recent Posts
Vaccitech Announces Pricing of Initial Public Offering
Vaccitech Appoints Joseph Scheeren, PharmD, to its Board of Directors
Vaccitech Doses First Patient in HPV001, a Phase 1/2 Clinical Trial of VTP-200 Immunotherapeutic for High-risk Persistent HPV Infection
Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results
Vaccitech Appoints Two Independent Board Directors
Archives
Archives
Select Month
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
April 2020
March 2020
January 2020
December 2019
November 2019
October 2019
August 2019
July 2019
June 2019
May 2019
March 2019
December 2018
October 2018
September 2018
June 2018
March 2018
January 2018
October 2017
November 2016
August 2016
July 2016